Why Seniors Need Different Seizure Medication After a Head Injury

The confusing part often starts after everyone is home. A parent has had a head injury, maybe after a fall, and the discharge papers now include an antiseizure medication. The bottle may say levetiracetam, phenytoin, lamotrigine, or another name that was never part of the household routine before. The immediate question is not academic: is this medication preventing a short-term complication, treating a seizure that already happened, or becoming part of daily life for months?

Epilepsy medication for seniors after head injury is chosen differently than it is for younger adults. That does not mean older patients should be left unprotected from seizures. Post-traumatic seizures are a real concern after traumatic brain injury, and caregiver-facing guidance notes that medications can control seizures in many people after TBI; one TBI factsheet describes seizure control in about 70% to 80% of people when antiseizure medicines are used appropriately.[1] A 2024 review also describes post-traumatic seizures as occurring in older adults after head injury, with estimates varying by injury severity.[2]

The difference is the trade-off. An 82-year-old who uses a walker, takes a blood thinner, has borderline kidney function, and recently fell is not facing the same medication bargain as a healthy 35-year-old. A drug that lowers seizure risk may also increase sleepiness, dizziness, imbalance, confusion, or another fall. In older adults, those side effects are not minor background noise; they can decide whether someone gets safely to the bathroom at night.

Why older adults are treated differently after TBI

The medication decision after a head injury has two separate questions. First, is the doctor trying to prevent an early post-traumatic seizure during the highest-risk period after injury? Second, has the person had a later seizure that suggests ongoing post-traumatic epilepsy treatment is needed? Those two situations can look the same on a medication list, but they are not the same plan.

Much of the direct trial evidence for antiseizure medication after TBI does not come from typical frail older adults. The 2024 systematic review and network meta-analysis of antiseizure medications in adult TBI reports mean participant ages across included trials ranging from 15 to 41 years, which limits how confidently those findings can be applied to people over 65.[2] For seniors, clinicians often have to combine post-traumatic seizure guidance with what is known about antiseizure medication use in older-adult epilepsy.

That older-adult pharmacology matters. Aging can reduce kidney and liver reserve, change how drugs are distributed in the body, and make the brain more sensitive to sedating or balance-disrupting medications. Practical Neurology’s 2024 review states that older adults often need only 25% to 75% of standard antiseizure medication doses, and that they may achieve seizure freedom at lower doses than younger adults.[3]

Why levetiracetam is so often on the discharge list

Levetiracetam is commonly favored in older adults because it solves several practical problems at once. It can be started and adjusted relatively quickly, it has few drug interactions compared with older antiseizure medications, and it usually does not require routine blood-level monitoring. For a senior who is already taking medications for blood pressure, cholesterol, diabetes, pain, sleep, or anticoagulation, fewer interactions are a serious advantage, not a convenience.[3]

Dose is where caregivers may notice the senior-specific approach most clearly. Practical Neurology notes that levetiracetam 250 to 500 mg twice daily is often adequate for older adults, compared with standard adult dosing of 500 to 1,500 mg twice daily.[3] That lower-looking dose is not necessarily timid prescribing. It may be the right dose for an older body that clears medication more slowly or reacts more strongly.

Levetiracetam is not side-effect-free. Its important household signal is behavioral change: new irritability, agitation, moodiness, tearfulness, or a personality shift that does not fit the person’s usual recovery pattern. One study cited in the older-adult epilepsy review reports behavioral adverse effects in about 6% of older adults taking levetiracetam.[3] That percentage is not high enough to make the drug a poor choice for everyone, but it is high enough that a daughter or spouse should not dismiss a sudden change as “just getting older.”

Where lamotrigine fits, and why it is not always simple after injury

Lamotrigine is another medication often viewed favorably for older adults with epilepsy. It has a relatively favorable cognitive profile and may be helpful when mood symptoms are part of the picture.[3] For a senior who is already vulnerable to confusion or slowed thinking after a head injury, avoiding extra cognitive burden matters.

The limitation is timing. Lamotrigine has to be increased slowly because rapid titration raises the risk of serious rash, including Stevens-Johnson syndrome.[3] That makes it less useful when a clinician needs immediate seizure coverage after an acute injury. It may be considered more often for longer-term treatment planning than for a quick discharge-start medication, depending on the clinical situation.

There is also a cardiac caution. Practical Neurology notes an FDA warning about possible arrhythmia risk with lamotrigine in people with certain cardiac conditions.[3] For an older adult with known conduction disease, arrhythmias, unexplained fainting, or multiple heart medications, that history belongs in the prescribing conversation.

Why older drugs raise more concern in seniors

Phenytoin has a long history in seizure prevention after head injury, so families may still see it used, especially around hospital protocols. The problem is what happens when a familiar hospital drug becomes a messy home medication for an older adult. Practical Neurology reports that up to 90% of older adults on phenytoin report side effects, compared with 50% on lamotrigine.[3] It also describes phenytoin as having a narrower therapeutic window in aging patients, meaning the space between helpful and harmful can become uncomfortably small.[3]

Phenytoin is also interaction-heavy. It can interact with blood thinners, statins, antihypertensives, and other common medications in an older adult’s pill organizer.[3] That matters after a fall-related head injury because the same person may already be taking anticoagulants or cardiovascular drugs. If the antiseizure medication changes the effect of those medicines, the seizure plan has quietly become a whole-medication-list problem.

Bone health is another reason phenytoin and other enzyme-inducing antiseizure medications deserve caution. Practical Neurology notes that enzyme-inducing antiseizure medications accelerate vitamin D catabolism, compounding osteoporosis risk, and reports that phenytoin is associated with a twofold greater rate of bone density loss per year.[3] For a senior whose head injury began with a fall, a medication that may worsen bone vulnerability is not a small footnote.

Carbamazepine raises similar practical worries because of drug interactions and hyponatremia risk, which means low sodium can become part of the confusion, weakness, or fall-risk picture.[3] Phenobarbital is especially difficult in older adults because sedation and cognitive impairment can be pronounced. Valproate can be effective across seizure types, but tremor, weight gain, and cognitive side effects may make it hard for some seniors to tolerate. These are not “bad drugs” in every patient; they are drugs that demand a much higher level of justification in a frail older adult.

Short-term prevention is different from long-term treatment

A seizure medication after TBI may be prescribed for short-term prophylaxis even if no seizure has occurred. In a global survey of 220 neurosurgeons and neurologists, 91.8% reported starting prophylactic antiepileptic drugs after TBI, and most stopped within 2 weeks if no seizure occurred.[4] That survey describes practice patterns, not a universal rule for every patient, but it explains why a caregiver may see an antiseizure drug appear automatically after hospitalization.

Some clinical protocols are even more specific. UTHealth’s post-traumatic seizure prophylaxis guideline, revised in July 2024, describes a standard 7-day prophylaxis approach for patients with TBI.[5] A seven-day plan and a months-long epilepsy treatment plan should not be allowed to blur together at home. If the discharge paperwork does not say how long the medication is expected to continue, that is a reason to ask.

The decision changes if a late seizure occurs. The same global survey reports that when a late post-traumatic seizure occurs, treatment commonly continues for 3 to 12 months.[4] That does not mean every senior should stop at 3 months or continue for 12. It means the medication is no longer just a short hospital-prevention measure; it has become a treatment plan that deserves review around dose, kidney function, liver function, side effects, and daily safety.

The side effects that matter at home

Caregivers are often told to watch for side effects, but the useful question is which side effects should change behavior. In an older adult after head injury, the practical list is sleepiness, dizziness, balance problems, new confusion, slowed thinking, mood changes, agitation, and any increase in near-falls or actual falls. If those symptoms begin soon after starting or increasing an antiseizure medication, the prescriber needs that timeline.

Fall risk is not theoretical. A systematic review of antiepileptic drug use in ambulatory older adults found relative risks for falls ranging from 1.29 to 1.62 among people using these medications.[6] Mayo Clinic also lists anti-seizure medicines among medication classes that can increase fall risk in older adults.[7] For a broader medication-list check, caregivers may need to compare the seizure medication with other sedating or balance-disrupting drugs in a caregiver’s guide to medications that increase fall risk in older adults.

A medication organizer can hide patterns as easily as it can prevent missed doses. If a parent is sleepy every morning, unsteady after the evening dose, or suddenly more irritable after a dose change, write down the time, dose, symptom, and what else was taken nearby. That kind of record is more useful to a clinician than a general statement that the parent “seems worse.” For the larger work of reconciling prescriptions after a hospitalization, medication management for older adults can help caregivers build a cleaner list before calling the doctor.

Lacosamide is worth mentioning because it is another newer option that may be considered in some patients. A 2025 pharmacotherapy review describes lacosamide as generally well tolerated, while also noting dizziness as a common side effect.[8] In a younger adult, dizziness may be annoying. In a senior who already fell once, dizziness may decide whether the person can safely stand from a chair.

What to ask before the medication becomes routine

The goal is not for caregivers to choose the antiseizure medication themselves. The goal is to make sure the plan reflects the older adult in front of the prescriber: kidney function, liver function, heart history, fall history, bone health, current medication list, and whether the medication is temporary prophylaxis or treatment after a seizure.

• What is the goal of this medication: short-term seizure prevention after the injury, or treatment because a seizure occurred?
• How long is it expected to continue, and who will decide whether to stop, taper, or continue it?
• Is the dose adjusted for kidney function, liver function, age, weight, and frailty?
• Which side effects should trigger a call the same day: severe sleepiness, worsening confusion, new agitation, dizziness, rash, falls, or near-falls?
• Does this medication interact with blood thinners, heart medications, statins, antidepressants, sleep aids, pain medications, or supplements?
• If the medication can affect bone health, should vitamin D, calcium intake, osteoporosis risk, or bone-density follow-up be reviewed?

If the head injury followed a fall, the medication conversation should sit beside the fall conversation. Once urgent medical issues are stable, families may need a plan for what to do after an elderly parent falls at home and practical home changes such as bathroom safety for seniors.

For many seniors after head injury, levetiracetam or lamotrigine may fit the risk profile better than older antiseizure drugs, but the safest choice is never just the newest medication or the smallest dose. It is a senior-specific plan that prevents seizures without quietly worsening falls, cognition, mood, bone health, or drug interactions.

References

1. Seizures After Traumatic Brain Injury (TBI), Model Systems Knowledge Translation Center.
2. Antiseizure Medications in Adult Patients With Traumatic Brain Injury: A Systematic Review and Bayesian Network Meta-Analysis, PMC, 2024.
3. Pharmacologic Considerations in the Treatment of Older Adults With Epilepsy, Practical Neurology, 2024.
4. Use of Anti-epileptic Drugs for Post Traumatic Seizure: A Global Survey, PMC.
5. Post-Traumatic Seizure Prophylaxis in Patients with TBI, UTHealth, revised July 2024.
6. Risk of falls associated with antiepileptic drug use in ambulatory elderly populations: A systematic review, PMC.
7. Medicines that increase fall risk in older adults, Mayo Clinic, 2025.
8. Post-traumatic epilepsy: bridging pathogenesis, diagnosis, and pharmacotherapeutic strategies, Frontiers in Pharmacology, 2025.